Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Shanlian Hu, Depei Wu, Jing Wu, Yabing Zhang, Mette Bøgelund, Johannes Pöhlmann & Richard F Pollock. (2023) Disutilities Associated with Intravenous Iron Infusions: Results from a Time Trade-off Survey and Diminishing Marginal Utility Model for Treatment Attributes in China. Patient Related Outcome Measures 14, pages 253-267.
Read now
Read now
Tariq H Iqbal, Nicholas Kennedy, Anjan Dhar, Waqas Ahmed & Richard F. Pollock. Cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anemia in England. Journal of Medical Economics 0:0, pages 1-19.
Read now
Read now
Articles from other publishers (2)
Lu Yun, Zhu YuMei, Vallish BN, Qingu Tang & Chang Feng. (2023) The Efficacy, Safety, and Economic Outcomes of Using Ferric Derisomaltose for the Management of Iron Deficiency in China: A Rapid Health Technology Assessment. Cureus.
Crossref
Crossref
L. D. Belotserkovtseva, L. V. Kovalenko, V. N. Zinin, S. E. Ivannikov & M. R. Keldasova. (2023) Iron deficiency anemia in pregnant women. Ural Medical Journal 22:5, pages 140-149.
Crossref
Crossref